Article
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells.
The Journal of experimental medicine - 6 Jul 2020
Bowyer Georgina, Sharpe Hannah, Venkatraman Navin, Ndiaye Pierre Birahim, Wade Djibril, Brenner Nicole, Mentzer Alex, Mair Catherine, Waterboer Tim, Lambe Teresa, Dieye Tandakha, Mboup Souleymane, Hill Adrian V S, Ewer Katie J
Abstract excerpt
CMV is associated with immunosenescence and reduced vaccine responses in the elderly (>70 yr). However, the impact of CMV in young adults is less clear. In this study, healthy UK and Senegalese adults aged 18-50 yr (average, 29 yr) were vaccinated with the Ebola vaccine candidate chimpanzee adenovirus type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) and boosted with modified vaccinia Ankara Ebola Zaire-vectored...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
